Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
M40403 for Prevention of IL-2 Induced Hypotension
NCT00033956Phase 2Suspended
- Sponsor
- Metaphore Biotechnologies
- Start
- Dec 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of imisopasem manganese in hypotension, sponsored by Metaphore Biotechnologies. Started Dec 2001; status: suspended.
02
Drugs
imisopasem manganese
03
Conditions
hypotension
Beyond the preview
Go deeper on NCT00033956.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00033956.